Novel self-nanomicellizing solid dispersion based on rebaudioside A: A potential nanoplatform for oral delivery of curcumin

International Journal of Nanomedicine

Volumn 14, Issue , 2019, Pages 557-571

  Hou, Yuzhen ^a   Wang, Hui ^a   Zhang, Fan ^a   Sun, Fengyuan ^a   Xin, Meng ^a,b   Li, Mengshuang ^a,c   Li, Jun ^d   Wu, Xianggen ^a  

^a QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c QINGDAO WOMEN AND CHILDREN S HOSPITAL   (China)

^d SHANDONG EYE INSTITUTE   (China)

Author keywords

Curcumin; Drug delivery; Micelle; Rebaudioside A; Self nanomicellizing; Solid dispersion

Indexed keywords

CURCUMIN; NANOPARTICLE; REBAUDIOSIDE A; UNCLASSIFIED DRUG; DEXTRAN SULFATE; KAURANE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT LOSS; CONTROLLED STUDY; DISPERSION; DISPERSITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; DUODENUM; ENDOCYTOSIS; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; JEJUNUM; MALE; MEMBRANE PERMEABILITY; MICELLE; MICELLIZATION; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHARMACOKINETIC PARAMETERS; RAT; SOLID STATE; SPLEEN WEIGHT; TRANSCYTOSIS; ULCERATIVE COLITIS; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; MOUSE; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; COLITIS; CURCUMIN; DEXTRAN SULFATE; DITERPENES, KAURANE; DRUG DELIVERY SYSTEMS; MALE; MICE; MICELLES; RATS; TISSUE DISTRIBUTION;

EID: 85060205881     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S191337     Document Type: Article

References (47)

1. Wang Y, Li L, Wang Y, et al. New application of the commercial sweetener rebaudioside a as a hepatoprotective candidate: Induction of the Nrf2 signaling pathway. Eur J Pharmacol. 2018;822:128–137.
2. Thøgersen R, Petrat-Melin B, Zamaratskaia G, Grevsen K, Young JF, Rasmussen MK. In vitro effects of rebaudioside A, stevioside and steviol on porcine cytochrome p450 expression and activity. Food Chem. 2018; 258:245–253.
3. Zhang M, Dai T, Feng N. A Novel Solubility-Enhanced Rubusoside-Based Micelles for Increased Cancer Therapy. Nanoscale Res Lett. 2017;12(1):274–258.
4. Song K, Xin M, Yu H, et al. Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery. Int J Pharm. 2018;552(1–2):265–276.
5. Platania CBM, Fidilio A, Lazzara F, et al. Retinal Protection and Distribution of Curcumin in Vitro and in Vivo. Front Pharmacol. 2018;9:670.
6. Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med. 2018;16(6):367–374.
7. Zhang J, Chou G, Liu Z, Liu M. Employing rubusoside to improve the solubility and permeability of antitumor compound betulonic acid. Nanomedicine. 2016;29(14):2829–2844.
8. Wan ZL, Wang JM, Wang LY, Yang XQ, Yuan Y. Enhanced physical and oxidative stabilities of soy protein-based emulsions by incorporation of a water-soluble stevioside-resveratrol complex. J Agric Food Chem. 2013;61(18):4433–4440.
9. Uchiyama H, Tozuka Y, Nishikawa M, Takeuchi H. Nanocomposite formation between alpha-glucosyl stevia and surfactant improves the dissolution profile of poorly water-soluble drug. Int J Pharm. 2012; 428(1–2):183–186.
10. Zhang F, Koh GY, Jeansonne DP, et al. A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. J Pharm Sci. 2011;100(7):2778–2789.
11. Zhang F, Koh GY, Hollingsworth J, Russo PS, Stout RW, Liu Z. Reformulation of etoposide with solubility-enhancing rubusoside. Int J Pharm. 2012;434(1–2):453–459.
12. Uchiyama H, Tozuka Y, Imono M, Takeuchi H. Transglycosylated stevia and hesperidin as pharmaceutical excipients: dramatic improvement in drug dissolution and bioavailability. Eur J Pharm Biopharm. 2010;76(2):238–244.
13. Wang H, Cui Y, Fu Q, et al. A phospholipid complex to improve the oral bioavailability of flavonoids. Drug Dev Ind Pharm. 2015;41(10): 1693–1703.
14. Guo C, Zhang Y, Yang Z, et al. Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation. Sci Rep. 2015;5(1):12968.
15. Guo C, Cui F, Li M, Li F, Wu X. Enhanced corneal permeation of coumarin-6 using nanoliposomes containing dipotassium glycyrrhiz-inate: in vitro mechanism and in vivo permeation evaluation. RSC Adv. 2015;5(92):75636–75647.
16. Xu T, Xu X, Gu Y, Fang L, Cao F. Functional intercalated nanocom-posites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery. Int J Nanomedicine. 2018;13:917–937.
17. Kumar S, Kesharwani SS, Mathur H, Tyagi M, Bhat GJ, Tummala H. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci. 2016;82:86–96.
18. Yang R, Zhang S, Kong D, Gao X, Zhao Y, Wang Z. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res. 2012;29(12):3512–3525.
19. Jahanshiri Z, Shams-Ghahfarokhi M, Allameh A, Razzaghi-Abyaneh M. Effect of Curcumin on Aspergillus parasiticus Growth and Expression of Major Genes Involved in the Early and Late Stages of Aflatoxin Biosynthesis. Iran J Public Health. 2012;41(6):72–79.
20. Ge W, Li D, Chen M, Wang X, Liu S, Sun R. Characterization and antioxidant activity of β-carotene loaded chitosan-graft-poly(lactide) nanomicelles. Carbohydr Polym. 2015;117:169–176.
21. Cheng B, Pan H, Liu D, et al. Functionalization of nanodiamond with vitamin E TPGS to facilitate oral absorption of curcumin. Int J Pharm. 2018;540(1–2):162–170.
22. Chen Q, Gou S, Huang Y, et al. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue. Colloids Surf B Biointerfaces. 2018;169:92–98.
23. Zhang Q, Polyakov NE, Chistyachenko YS, et al. Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. Drug Deliv. 2018;25(1): 198–209.
24. Xiao B, Si X, Zhang M, Merlin D. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy. Colloids Surf B Biointerfaces. 2015;135:379–385.
25. Lean QY, Eri RD, Fitton JH, Patel RP, Gueven N. Fucoidan Extracts Ameliorate Acute Colitis. PLoS One. 2015;10(6):e0128453.
26. Suzuki H, Ueno K, Mizumoto T, Seto Y, Sato H, Onoue S. Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments. Eur J Pharm Sci. 2017;96:107–114.
27. Onoue S, Suzuki H, Kojo Y, et al. Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability. Eur J Pharm Sci. 2014;62:16–22.
28. Shi NQ, Zhang Y, Li Y, et al. Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms. Int J Pharm. 2017;528(1–2):563–577.
29. Li M, Xin M, Guo C, Lin G, Wu X. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Drug Dev Ind Pharm. 2017;43(11): 1846–1857.
30. Weuts I, Kempen D, Six K, et al. Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs. Int J Pharm. 2003;259(1–2): 17–25.
31. Yu H, Huang Q. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem. 2010; 119(2):669–674.
32. Saravanan R, Ramachandran V. Modulating efficacy of Rebaudioside A, a diterpenoid on antioxidant and circulatory lipids in experimental diabetic rats. Environ Toxicol Pharmacol. 2013;36(2):472–483.
33. Kim KS, Suzuki K, Cho H, Youn YS, Bae YH. Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport. ACS Nano. 2018;12(9):8893–8900.
34. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm. 2000;50(1):147–160.
35. Agrawal U, Sharma R, Gupta M, Vyas SP. Is nanotechnology a boon for oral drug delivery? Drug Discov Today. 2014;19(10):1530–1546.
36. Lu Z, Bu C, Hu W, et al. Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery. Biosci Biotechnol Biochem. 2018;82(2):238–246.
37. Sun F, Jaspers TC, van Hasselt PM, Hennink WE, van Nostrum CF. A Mixed Micelle Formulation for Oral Delivery of Vitamin K. Pharm Res. 2016;33(9):2168–2179.
38. Feng B, Mills JB, Davidson RE, et al. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Drug Metab Dispos. 2008;36(2):268–275.
39. Mensch J, Melis A, Mackie C, Verreck G, Brewster ME, Augustijns P. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability. Eur J Pharm Biopharm. 2010;74(3):495–502.
40. Sun H, Nguyen K, Kerns E, et al. Highly predictive and interpretable models for PAMPA permeability. Bioorg Med Chem. 2017;25(3):1266–1276.
41. Avdeef A, Nielsen PE, Tsinman O. PAMPA – a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Eur J Pharm Sci. 2004; 22(5):365–374.
42. Pauletti GM, Okumu FW, Borchardt RT. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res. 1997;14(2):164–168.
43. Saw WS, Ujihara M, Chong WY, et al. Size-dependent effect of cystine/citric acid-capped confeito-like gold nanoparticles on cellular uptake and photothermal cancer therapy. Colloids Surf B Biointerfaces. 2018;161:365–374.
44. Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014; 104:Unit 15.25.
45. Kao NJ, Hu JY, Wu CS, Kong ZL. Curcumin represses the activity of inhibitor-κB kinase in dextran sulfate sodium-induced colitis by S-nitrosylation. Int Immunopharmacol. 2016;38:1–7.
46. Yang H, Du Z, Wang W, et al. Structure-Activity Relationship of Curcumin: Role of the Methoxy Group in Anti-inflammatory and Anticolitis Effects of Curcumin. J Agric Food Chem. 2017;65(22):4509–4515.
47. Ameer K, Bae SW, Jo Y, Lee HG, Ameer A, Kwon JH. Optimization of microwave-assisted extraction of total extract, stevioside and rebaudioside-A from Stevia rebaudiana (Bertoni) leaves, using response surface methodology (RSM) and artificial neural network (ANN) modelling. Food Chem. 2017;229:198–207.